tiprankstipranks
BioNexus Gene Lab Corp (BGLC)
NASDAQ:BGLC
US Market
BGLC
BioNexus Gene Lab Corp
RESEARCH TOOLSreports
Want to see BGLC full AI Analyst Report?

BioNexus Gene Lab Corp (BGLC) Financial Statements

111 Followers

BioNexus Gene Lab Corp Financial Overview

BioNexus Gene Lab Corp's market cap is currently $4.93M. The company's EPS TTM is $-1.61; its P/E ratio is -1.77; BioNexus Gene Lab Corp is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 7.42M$ 9.51M$ 9.77M$ 10.93M$ 13.36M
Gross Profit$ 1.09M$ 1.29M$ 1.33M$ 1.26M$ 2.19M
Operating Income$ -3.16M$ -1.57M$ -2.59M$ -291.18K$ 1.06M
EBITDA$ -2.80M$ -1.42M$ -2.49M$ -185.76K$ 1.16M
Net Income$ -2.98M$ -1.60M$ -2.63M$ -355.97K$ 751.57K
Balance Sheet
Cash & Short-Term Investments$ 2.38M$ 4.38M$ 5.93M$ 2.12M$ 2.12M
Total Assets$ 9.25M$ 10.43M$ 11.40M$ 8.74M$ 9.57M
Total Debt$ 176.05K$ 210.56K$ 146.59K$ 56.77K$ 76.95K
Net Debt$ -2.21M$ -4.17M$ -5.78M$ -2.06M$ -2.05M
Total Liabilities$ 637.86K$ 2.11M$ 1.74M$ 2.08M$ 2.39M
Stockholders' Equity$ 8.61M$ 8.32M$ 9.66M$ 6.67M$ 7.18M
Cash Flow
Free Cash Flow$ -1.88M$ -2.46M$ -1.91M$ 497.65K$ 6.00K
Operating Cash Flow$ -1.84M$ -2.23M$ -1.76M$ 551.82K$ 9.16K
Investing Cash Flow$ 944.75K$ 418.20K$ -1.86M$ -450.50K$ -490.57K
Financing Cash Flow$ 298.84K$ 144.97K$ 6.27M$ 108.17K$ -28.22K
Currency in USD

BioNexus Gene Lab Corp Earnings and Revenue History

Income Statement >

BioNexus Gene Lab Corp Debt to Assets

Balance Sheet >

BioNexus Gene Lab Corp Cash Flow

Cash Flow >

BioNexus Gene Lab Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >